loader
Please Wait
Applying Filters...
Close
4

M2i Group Roflumilast M2i Group Roflumilast

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Drug Approvals by the Medicines Control Council in South Africa containing 3-(CYCLOPROPYLMETHOXY)-N-(3,5-DICHLOROPYRIDIN-4-YL)-4-(DIFLUOROMETHOXY)BENZAMIDE. Original Data : South African Medicines Price Registry

    Client Email Product
    Menu

    3-Cyclopropylmethoxy-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Forms

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    REF. STANDARDS & IMPURITIES

    DIGITAL CONTENT

    PharmaCompass

    PharmaCompass Sponsored Ads

    Skyepharma, an Expert and Innovative CDMO Partner for tailor-made solutions in complex oral solids and bioproduction.

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Astrazeneca Pharmaceuticals (Pty) Ltd (1)

    filter

    01 Roflumilast (1)

    filter

    01 FCT (1)

    filter

    01 Daxas 500 µg (1)

    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Astrazeneca Pharmaceuticals (Pty) L...

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Roflumilast

    PDF Supplier PDF
    URL Supplier Web Content
    FCT
    500mcg
    Daxas 500 µg
    30X1mcg
    Originator
    South Africa
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Post Enquiry
    POST ENQUIRY